In summary, our data demonstrate that CCR2-shRNA loaded ENP could be effectively up taken by atherosclerotic cellular model of macrophages and target-silence their CCR2 mRNA expressions, which suggests the nanoparticle’s potential application for therapy of atherosclerosis. The gene discussed is CCR2; the disease is atherosclerosis.